17-17793779-CCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_030665.4(RAI1):​c.870_872dupGCA​(p.Gln291dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,356,272 control chromosomes in the GnomAD database, including 42 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 26 hom., cov: 0)
Exomes 𝑓: 0.020 ( 16 hom. )

Consequence

RAI1
NM_030665.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.36
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 17-17793779-C-CCAG is Benign according to our data. Variant chr17-17793779-C-CCAG is described in ClinVar as [Benign]. Clinvar id is 130086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.0330
AC:
2599
AN:
78794
Hom.:
27
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0351
Gnomad ASJ
AF:
0.0300
Gnomad EAS
AF:
0.00533
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.0307
Gnomad MID
AF:
0.0281
Gnomad NFE
AF:
0.0374
Gnomad OTH
AF:
0.0282
GnomAD4 exome
AF:
0.0205
AC:
26172
AN:
1277388
Hom.:
16
Cov.:
38
AF XY:
0.0213
AC XY:
13483
AN XY:
631784
show subpopulations
Gnomad4 AFR exome
AF:
0.0140
Gnomad4 AMR exome
AF:
0.0184
Gnomad4 ASJ exome
AF:
0.0165
Gnomad4 EAS exome
AF:
0.00177
Gnomad4 SAS exome
AF:
0.0408
Gnomad4 FIN exome
AF:
0.0188
Gnomad4 NFE exome
AF:
0.0202
Gnomad4 OTH exome
AF:
0.0184
GnomAD4 genome
AF:
0.0329
AC:
2598
AN:
78884
Hom.:
26
Cov.:
0
AF XY:
0.0344
AC XY:
1289
AN XY:
37498
show subpopulations
Gnomad4 AFR
AF:
0.0240
Gnomad4 AMR
AF:
0.0351
Gnomad4 ASJ
AF:
0.0300
Gnomad4 EAS
AF:
0.00535
Gnomad4 SAS
AF:
0.145
Gnomad4 FIN
AF:
0.0307
Gnomad4 NFE
AF:
0.0373
Gnomad4 OTH
AF:
0.0287

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Oct 16, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 30, 2015
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 06, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Apr 08, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RAI1: BS1, BS2 -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Apr 18, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371983878; hg19: chr17-17697093; API